Reuters logo
1 个月前
BRIEF-Mallinckrodt phase 3 Terlipressin trial achieves enrollment target ahead of schedule
2017年7月13日 / 晚上8点56分 / 1 个月前

BRIEF-Mallinckrodt phase 3 Terlipressin trial achieves enrollment target ahead of schedule

July 13 (Reuters) - Mallinckrodt Plc:

* Mallinckrodt phase 3 Terlipressin trial achieves its enrollment target ahead of schedule Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below